Johnson & Johnson says its marketing practices being investigated

Sat Feb 23, 2013 7:29am IST

Stocks

   

(Reuters) - Johnson & Johnson (JNJ.N) said on Friday the U.S. Justice Department is investigating the company's marketing practices related to the hip-replacement product it recalled in 2010 over safety concerns.

The diversified healthcare company has also had to recall over-the-counter drugs, contact lenses, heart devices, such as stents, and insulin pump cartridges over the past couple of years.

In August 2010, J&J recalled two types of its ASR metal-on-metal hip implants after they were linked to high failure rates.

Some 93,000 of the ASR hips were sold prior to the recall, which has generated more than 10,000 lawsuits alleging harm from the devices.

J&J said in a regulatory filing that the government is investigating false claims or false statements affecting federal health care programs in connection with the marketing and use of the ASR XL Hip device.

The company said some of its divisions received an informal request in August 2012 from the U.S. attorney's office in Massachusetts and the Justice Department's civil division seeking materials related to the product, the ASR XL Hip device.

J&J said it has voluntarily produced documents in response to the government's informal requests and is fully cooperating with the government's civil investigation.

(Reporting by Neha Alawadhi in Bangalore; Editing by Jackie Frank)

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.

  • Most Popular
  • Most Shared

Kerry in India

REUTERS SHOWCASE

Deadly Landslide

Deadly Landslide

Landslide near Pune kills 10, scores feared trapped.  Full Article 

Fed Policy

Fed Policy

Fed presses forward with bond buying, cites uptick in inflation.  Full Article 

Big Infra Deal

Big Infra Deal

Piramal, Dutch APG tie up for $1 bln infra investment  Full Article 

E-Commerce

E-Commerce

Amazon says to invest $2 billion more in India   Full Article 

Lupin Results

Lupin Results

Q1 net profit up 56 percent on higher U.S. drug sales   Full Article 

Smuggling Gold

Smuggling Gold

Air India staff found smuggling gold  Full Article 

Economy Reboots

Economy Reboots

U.S. economy back on track with strong second-quarter rebound .  Full Article 

Auto Sector

Auto Sector

VW closes in on Toyota as global auto leader  Full Article 

Expanding Reach

Expanding Reach

Tata to invest $35 bln over 3 years, focus on new businesses   Full Article 

Reuters India Mobile

Reuters India Mobile

Get the latest news on the go. Visit Reuters India on your mobile device.  Full Coverage